½ÃÀ庸°í¼­
»óǰÄÚµå
1786816

¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼®(Á¦Ç° ¹× ¼­ºñ½ºº°, À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°) ¹× ¿¹Ãø(2025-2034³â)

Microarray Market Size, Share, Trends, Industry Analysis Report By Product & Services (Consumables, Software & Services, Instruments), By Type, By Application, By End Use, By Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 98¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀåÀº °úÇÐÀÚµéÀÌ ¼öõ °³ÀÇ »ý¹°ÇÐÀû »ùÇÃÀ» µ¿½Ã¿¡ ºÐ¼®ÇÒ ¼ö ÀÖ´Â ±â¼úÀ» Áß½ÉÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â ±âº»ÀûÀ¸·Î À¯¸®·Î ¸¸µç ÀÛÀº ĨÀ¸·Î, ¼ö¸¹Àº ÀÛÀº Á¡µéÀÌ ÆÐÅÏÀ¸·Î ¹è¿­µÇ¾î ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. °¢ ½ºÆÌ¿¡´Â DNA, ´Ü¹éÁú µî ƯÁ¤ ÇÁ·Îºê°¡ Æ÷ÇԵǾî ÀÖ¾î ½Ã·áÀÇ Ç¥Àû ºÐÀÚ¿Í °áÇÕÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¿¬±¸ÀÚµéÀº À¯ÀüÀÚ È°¼º, À¯ÀüÀÚ µ¹¿¬º¯ÀÌ, ´Ü¹éÁúÀÇ »óÈ£ÀÛ¿ë¿¡ ´ëÇÑ ¸¹Àº Á¤º¸¸¦ ºü¸£°Ô ¾òÀ» ¼ö ÀÖ¾î ´Ù¾çÇÑ »ý¹°ÇÐÀû, ÀÇÇÐÀû ¿¬±¸¸¦ À§ÇÑ °­·ÂÇÑ µµ±¸°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â »ý¸í°øÇÐ ¹× À¯ÀüüÇÐ »ê¾÷ÀÇ ¼ºÀå ºÐ¾ßÀÔ´Ï´Ù. ºÐÀÚ ¼öÁØ¿¡¼­ÀÇ Áúº´ ÀÌÇØ¿¡ ´ëÇÑ °ü½É Áõ°¡, ¸ÂÃãÇü ÀÇ·á Á¢±Ù ¹æ½ÄÀ¸·ÎÀÇ Àüȯ, À¯ÀüÀÚ ¿¬±¸ÀÇ ²÷ÀÓ¾ø´Â ±â¼ú Çõ½Å µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ Å« ¹ßÀüÀ» ÀÌ·ç¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â Áúº´ Áø´Ü, ½Å¾à °³¹ß, ±âÃÊ »ý¹°ÇÐ ¿¬±¸ µîÀÇ ºÐ¾ß¿¡¼­ ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖÀ¸¸ç, Áß¿äÇÑ ºÐÀÚÀû ÀλçÀÌÆ®¸¦ ¼öÁýÇÒ ¼ö ÀÖ´Â ³ôÀº 󸮷®°ú È¿À²ÀûÀÎ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù.

¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¦Ç° ¹× ¼­ºñ½ºº°·Î´Â ½Ã¾à, ÇÁ·Îºê, ½½¶óÀÌµå µî ¼Ò¸ðǰÀÌ 2024³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¼Ò¸ðǰÀÇ Á¤±âÀûÀÎ ±¸¸Å´Â ´Ù¾çÇÑ ¿¬±¸ ¹× Áø´Ü ÀÀ¿ë ºÐ¾ß¿¡¼­ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¼úÀÌ Áö¼ÓÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ´Â ¹è°æ¿¡ ±âÀÎÇÕ´Ï´Ù.

À¯Çüº°·Î´Â DNA ¸¶ÀÌÅ©·Î¾î·¹À̰¡ À¯ÀüÀÚ ¿¬±¸, Áø´Ü, ½Å¾à°³¹ß¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ¸é¼­ 2024³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. DNA ¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â À¯ÀüÀÚ ¹ßÇö ¿¬±¸¿Í À¯ÀüÀÚ µ¹¿¬º¯ÀÌ È®Àο¡ ÇʼöÀûÀ̸ç, Áúº´À» ÀÌÇØÇÏ°í ¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ýÀ» °³¹ßÇÏ´Â µ¥ ÀÖ¾î ±âº»ÀûÀÎ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù.

¿ëµµº°·Î´Â ¿¬±¸ ¿ëµµ ºÐ¾ß°¡ 2024³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â º¹ÀâÇÑ »ý¹°ÇÐÀû °úÁ¤À» ÀÌÇØÇϱâ À§ÇÑ ÇмúÀû, °úÇÐÀû ¿¬±¸¿¡ ³Î¸® »ç¿ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. À¯ÀüÀÚ ¹ßÇö ÇÁ·ÎÆÄÀϸµ, À¯ÀüÀÚÇü ºÐ¼®, ÈÄ»ýÀ¯ÀüÇÐ ¿¬±¸ µî ´Ù¾çÇÑ ±â°ü¿¡¼­ ´Ù¿ëµµ·Î »ç¿ëµÇ°í ÀÖ´Ù´Â Á¡ÀÌ ÀÌ ºÎ¹®ÀÇ ¼±µµÀû ÁöÀ§¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î´Â ±âÃʰúÇÐ ¿¬±¸¿Í ÷´Ü À¯ÀüüÇÐ ¹× ´Ü¹éÁúüÇÐ ¿¬±¸¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ³ë·ÂÀ¸·Î ÀÎÇØ ¿¬±¸ ¹× Çмú ±â°ü ºÎ¹®ÀÌ 2024³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â ÁַΠ÷´Ü ¿¬±¸ ÀÎÇÁ¶ó, À¯ÀüüÇÐ ¹× ´Ü¹éÁúüÇп¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ, ÁÖ¿ä »ý¸í°øÇÐ ¹× Á¦¾à ±â¾÷ÀÇ °­·ÂÇÑ Á¸Àç°¨ ¶§¹®ÀÎ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ »ê¾÷Àº À¯ÀüüÇп¡ ´ëÇÑ °ü½É Áõ°¡, ¾à¹° ½ºÅ©¸®´×¿¡¼­ÀÇ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¼ú Ȱ¿ë È®´ë, ¾Ï °ËÃâ¿¡ ´ëÇÑ Á߿伺 Áõ°¡ µîÀ» ¹è°æÀ¸·Î ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Agilent Technologies, Inc., Arrayit Corporation, Bio-Rad Laboratories, Inc., CD Genomics (Creative Biolabs), Illumina, Inc., Merck KGaA, Oxford Gene Technology (Danaher Corporation), PerkinElmer, Inc., RayBiotech, Inc., SCHOTT MINIFAB (SCHOTT AG), Takara Bio Inc., Thermo Fisher Scientific Inc. µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ¸¸¼ºÁúȯ ¹× °¨¿°Áõ ¸¸¿¬
      • ¸ÂÃãÇü ÀÇ·á ¼ö¿ä Áõ°¡
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
      • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â±â¿Í °ü·ÃµÈ °íºñ¿ë
  • PESTEL ºÐ¼®
  • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¼Ò¸ðǰ
  • ¼ÒÇÁÆ®¿þ¾î¿Í ¼­ºñ½º
  • ±â±â

Á¦6Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå : À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • DNA ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • ´Ü¹éÁú ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • ±âŸ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ

Á¦7Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¿¬±¸ ¿ëµµ
  • Drug Discovery
  • Áúº´ Áø´Ü
  • ±âŸ ¿ëµµ

Á¦8Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ÇмúÁ¶»ç±â°ü
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Áø´Ü °Ë»ç½Ç
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ½ÃÀå ºÐ¼® : Áö¿ª³â, 2020-2034³â
  • ºÏ¹Ì
    • ºÏ¹Ì : Á¦Ç° ¹× ¼­ºñ½ºº°, 2020-2034³â
    • ºÏ¹Ì : À¯Çüº°, 2020-2034³â
    • ºÏ¹Ì : ¿ëµµº°, 2020-2034³â
    • ºÏ¹Ì : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : Á¦Ç° ¹× ¼­ºñ½ºº°, 2020-2034³â
    • À¯·´ : À¯Çüº°, 2020-2034³â
    • À¯·´ : ¿ëµµº°, 2020-2034³â
    • À¯·´ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç° ¹× ¼­ºñ½ºº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : À¯Çüº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç° ¹× ¼­ºñ½ºº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À¯Çüº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç° ¹× ¼­ºñ½ºº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : À¯Çüº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦11Àå ±â¾÷ °³¿ä

  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • CD Genomics(Creative Biolabs)
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Gene Technology(Danaher Corporation)
  • PerkinElmer, Inc.
  • RayBiotech, Inc.
  • SCHOTT MINIFAB(SCHOTT AG)
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
KSM 25.08.21

The global microarray market size is expected to reach USD 9.87 billion by 2034, according to a new study by Polaris Market Research. The report "Microarray Market Size, Share, Trends, Industry Analysis Report By Product & Services (Consumables, Software & Services, Instruments), By Type, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The microarray market centers on technologies that enable scientists to analyze thousands of biological samples simultaneously. A microarray is essentially a small chip, often made of glass, which has many tiny spots arranged in a pattern. Each spot contains a specific probe, such as a piece of DNA or a protein, that can bind to target molecules from a sample. This allows researchers to quickly get a lot of information about gene activity, genetic variations, or protein interactions, making it a powerful tool for various biological and medical investigations.

The microarray is a growing segment of the biotechnology and genomics industry. It is experiencing significant development driven by several key factors such as the increasing focus on understanding diseases at a molecular level, rising shift toward personalized healthcare approaches, and continuous innovations in genetic research. These tools are becoming indispensable in areas such as disease diagnostics, drug discovery, and fundamental biological research, providing a high-throughput and efficient way to gather crucial molecular insights.

Microarray Market Report Highlights:

By product & services, the consumables segment held the largest share in 2024 as these items such as reagents, probes, and slides, are essential for every microarray experiment. Their recurring purchase is driven by the continuous use of microarray technology in various research and diagnostic applications.

By type, the DNA microarrays segment held the largest share in 2024 due to their broad use in genetic research, diagnostics, and drug discovery. They are crucial for studying gene expression and identifying genetic variations, making them a fundamental tool in understanding diseases and developing personalized medicine approaches.

By application, the research applications segment held the largest share in 2024, as microarrays are widely used in academic and scientific studies to understand complex biological processes. Their versatility in gene expression profiling, genotyping, and epigenetics research in various institutions drives this segment's leading position.

By end use, the research and academic institutes segment held the largest share in 2024 due to their continuous engagement in fundamental scientific research and advanced genomics and proteomics studies.

By region, North America held the largest share in 2024, primarily due to its advanced research infrastructure, significant investments in genomics and proteomics, and the strong presence of key biotechnology and pharmaceutical companies. The Asia Pacific microarray industry is experiencing rapid growth, driven by increasing genomics initiatives, the expanding use of microarray technology in drug screening, and its rising importance in cancer detection.

A few key players in the microarray market are Agilent Technologies, Inc.; Arrayit Corporation; Bio-Rad Laboratories, Inc.; CD Genomics (Creative Biolabs); Illumina, Inc.; Merck KGaA; Oxford Gene Technology (Danaher Corporation); PerkinElmer, Inc.; RayBiotech, Inc.; SCHOTT MINIFAB (SCHOTT AG); Takara Bio Inc.; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the microarray market report based on product & services, type, application, end use, and region:

By Product & Services Outlook (Revenue - USD Billion, 2020-2034)

Consumables

Software & Services

Instruments

By Type Outlook (Revenue - USD Billion, 2020-2034)

DNA Microarrays

Protein Microarrays

Other Microarrays

By Application Outlook (Revenue - USD Billion, 2020-2034)

Research Applications

Drug Discovery

Disease Diagnostics

Other Applications

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Research & Academic Institutes

Pharmaceutical & Biotechnology Companies

Diagnostic Laboratories

Other End Users

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Microarray Market Insights

  • 4.1. Microarray Market - Market Snapshot
  • 4.2. Microarray Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Chronic and Infectious Diseases
      • 4.2.1.2. Rising Demand for Personalized Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High costs associated with microarray instruments
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Microarray Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Microarray Market, by Product and Services

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Microarray Market, by Product and Services, 2020-2034 (USD Billion)
  • 5.3. Consumables
    • 5.3.1. Global Microarray Market, by Consumables, by Region, 2020-2034 (USD Billion)
  • 5.4. Software & Services
    • 5.4.1. Global Microarray Market, by Software & Services, by Region, 2020-2034 (USD Billion)
  • 5.5. Instruments
    • 5.5.1. Global Microarray Market, by Instruments, by Region, 2020-2034 (USD Billion)

6. Global Microarray Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Microarray Market, by Type, 2020-2034 (USD Billion)
  • 6.3. DNA Microarrays
    • 6.3.1. Global Microarray Market, by DNA Microarrays, by Region, 2020-2034 (USD Billion)
  • 6.4. Protein Microarrays
    • 6.4.1. Global Microarray Market, by Protein Microarrays, by Region, 2020-2034 (USD Billion)
  • 6.5. Other Microarrays
    • 6.5.1. Global Microarray Market, by Other Microarrays, by Region, 2020-2034 (USD Billion)

7. Global Microarray Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Microarray Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Research Applications
    • 7.3.1. Global Microarray Market, by Research Applications, by Region, 2020-2034 (USD Billion)
  • 7.4. Drug Discovery
    • 7.4.1. Global Microarray Market, by Drug Discovery, by Region, 2020-2034 (USD Billion)
  • 7.5. Disease Diagnostics
    • 7.5.1. Global Microarray Market, by Disease Diagnostics, by Region, 2020-2034 (USD Billion)
  • 7.6. Other Applications
    • 7.6.1. Global Microarray Market, by Other Applications, by Region, 2020-2034 (USD Billion)

8. Global Microarray Market, by End-Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Microarray Market, by End-Use, 2020-2034 (USD Billion)
  • 8.3. Research & Academic Institutes
    • 8.3.1. Global Microarray Market, by Research & Academic Institutes, by Region, 2020-2034 (USD Billion)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Global Microarray Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
  • 8.5. Diagnostic Laboratories
    • 8.5.1. Global Microarray Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
  • 8.6. Other End Users
    • 8.6.1. Global Microarray Market, by Other End Users, by Region, 2020-2034 (USD Billion)

9. Global Microarray Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Microarray Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Microarray Market - North America
    • 9.3.1. North America: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
    • 9.3.2. North America: Microarray Market, by Type, 2020-2034 (USD Billion)
    • 9.3.3. North America: Microarray Market, by Application, 2020-2034 (USD Billion)
    • 9.3.4. North America: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.3.5. Microarray Market - US
      • 9.3.5.1. US: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.3.6. Microarray Market - Canada
      • 9.3.6.1. Canada: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Microarray Market, by End-Use, 2020-2034 (USD Billion)
  • 9.4. Microarray Market - Europe
    • 9.4.1. Europe: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Microarray Market, by Type, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Microarray Market, by Application, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.5. Microarray Market - UK
      • 9.4.5.1. UK: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.6. Microarray Market - France
      • 9.4.6.1. France: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.7. Microarray Market - Germany
      • 9.4.7.1. Germany: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.8. Microarray Market - Italy
      • 9.4.8.1. Italy: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.9. Microarray Market - Spain
      • 9.4.9.1. Spain: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.10. Microarray Market - Netherlands
      • 9.4.10.1. Netherlands: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.11. Microarray Market - Russia
      • 9.4.11.1. Russia: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.4.12. Microarray Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Microarray Market, by End-Use, 2020-2034 (USD Billion)
  • 9.5. Microarray Market - Asia Pacific
    • 9.5.1. Asia Pacific: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Microarray Market, by Type, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Microarray Market, by Application, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.5. Microarray Market - China
      • 9.5.5.1. China: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.6. Microarray Market - India
      • 9.5.6.1. India: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.7. Microarray Market - Malaysia
      • 9.5.7.1. Malaysia: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.8. Microarray Market - Japan
      • 9.5.8.1. Japan: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.9. Microarray Market - Indonesia
      • 9.5.9.1. Indonesia: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.10. Microarray Market - South Korea
      • 9.5.10.1. South Korea: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.11. Microarray Market - Australia
      • 9.5.11.1. Australia: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.5.12. Microarray Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Microarray Market, by End-Use, 2020-2034 (USD Billion)
  • 9.6. Microarray Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Microarray Market, by Type, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Microarray Market, by Application, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.5. Microarray Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.6. Microarray Market - UAE
      • 9.6.6.1. UAE: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.7. Microarray Market - Israel
      • 9.6.7.1. Israel: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.8. Microarray Market - South Africa
      • 9.6.8.1. South Africa: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.6.9. Microarray Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Microarray Market, by End-Use, 2020-2034 (USD Billion)
  • 9.7. Microarray Market - Latin America
    • 9.7.1. Latin America: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Microarray Market, by Type, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Microarray Market, by Application, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.7.5. Microarray Market - Mexico
      • 9.7.5.1. Mexico: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.7.6. Microarray Market - Brazil
      • 9.7.6.1. Brazil: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.7.7. Microarray Market - Argentina
      • 9.7.7.1. Argentina: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Microarray Market, by End-Use, 2020-2034 (USD Billion)
    • 9.7.8. Microarray Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Microarray Market, by Product and Services, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Microarray Market, by Type, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Microarray Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Microarray Market, by End-Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Arrayit Corporation
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Bio-Rad Laboratories, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. CD Genomics (Creative Biolabs)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Illumina, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Merck KGaA
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Oxford Gene Technology (Danaher Corporation)
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. PerkinElmer, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. RayBiotech, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. SCHOTT MINIFAB (SCHOTT AG)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Takara Bio Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦